Idiopathic hypereosinophilic syndrome with eosinophilic myositis, peripheral neuropathy and central nervous system involvement

Journal of the Formosan Medical Association

Volumn 95, Issue 12, 1996, Pages 933-936

  Lee, Jiann Der ^a   Chen, Sien Tsong ^a   Chen, Chi Jen ^a   Chen, Chiung Mei ^a   Ro, Long Sun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

central nervous system; eosinophilic myositis; idiopathic hypereosinophilic syndrome; peripheral neuropathy

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; FEMALE; HUMAN; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC DISEASE; MYOSITIS; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; TAIWAN; ULTRASTRUCTURE;

CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; METHYLPREDNISOLONE; MIDDLE AGED; MYOSITIS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0030513233     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hardy WR, Anderson RE: The hypereosinophilic syndrome. Ann Intern Med 1968;68:1220-9.
2. Weller PF, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-79.
3. Chusid MJ, Dale DC, West BC, et al: The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 1975;54:1-27.
4. Moore PM, Harley JB, Fauci AS: Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 1985;102:109-14.
5. Ackerman SJ, Loegering DA, Venge P: Distinctive proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein and eosinophil-derived neurotoxin. J Immunol 1983;131:2977-82.
6. Fauci AS, Harley JB, Roberts WC, et al: The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982;97: 78-92.
7. Venge P, Dahl R, Hallgren R: Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res 1979;14:641-9.
8. Wichman A, Buchtal F, Pezeshkpour GH, et al: Peripheral neuropathy in hypereosinophilic syndrome. Neurology 1985;35:1140-5.
9. Monaco S, Lucci B, Laperchia N, et al: Polyneuropathy in hypereosinophilic syndrome. Neurology 1988;38:494-6.
10. Kaufman LD, Kephart GM, Seidman RJ, et al: The spectrum of eosinophilic myositis. Arthritis Rheum 1993;36: 1014-24.
11. Shulman LE: Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975;88:70-86.
12. Lanham JG, Elkon KB, Pusey CD, et al: Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984;63: 65-81.
13. Kaufman LD, Seidman RJ: L-tryptophan-associated eosinophilia-myalgia syndrome: perspective of a new illness. Rheum Dis Clin North Am 1991;17:427-41.
14. Fujisawa T, Abu-Ghaazaleh R, Kita H, et al: Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-6.
15. Weaver DF, Heffernan LP, Purdy RA, et al: Eosinophil-induced neurotoxicity: axonal neuropathy, cerebral infarction, and dementia. Neurology 1988;38:144-6.
16. Parrilo JE, Fauci AS, Wolff SM: Therapy of the hypereosinophilic syndrome. Ann Intern Med 1978;89: 167-72.
17. Bockenstedt PL, Santinga JT, Bolling SF: Alpha-interferon treatment for idiopathic hypereosinophilic syndrome. Am J Hematol 1994;45:248-51.
18. Fukushima T, Kuriyama K, Ito H, et al: Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome. Br J Haematol 1995;90:213-5.
19. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state": a practical method for grading the mental state of patients for the clinician. J Psychiat Res 1975;12:627-35.